Results 181 to 190 of about 32,499 (205)

Modified pullulan nanoparticles for oral delivery of lopinavir: Formulation and pharmacokinetic evaluation

Carbohydrate Polymers, 2014
Punna Rao Ravi, Rahul Vats
exaly  

Lopinavir

2017
openaire   +1 more source

Lopinavir/ritonavir

Reactions Weekly, 2002
openaire   +1 more source

Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz

British Journal of Clinical Pharmacology, 2005
Eric Dailly, Pascale Jolliet, François Raffi   +2 more
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Pharmacokinetics of Lopinavir/Ritonavir in HIV/Hepatitis C Virus–Coinfected Subjects With Hepatic Impairment

Journal of Clinical Pharmacology, 2006
Jose R. Arribas, Federico Pulido, Concepción Cepeda   +2 more
exaly  

Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

British Journal of Pharmacology, 2010
Jos Beijnen, A D R Huitema, A H Schinkel
exaly  

Lopinavir/ritonavir

Reactions Weekly, 2017
openaire   +2 more sources

Lopinavir/ritonavir

Reactions Weekly, 2009
openaire   +2 more sources

Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin

British Journal of Clinical Pharmacology, 2013
Paolo Denti, Helen McIlleron, Mats O Karlsson   +2 more
exaly